Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 39075719 | 0 | Porres-Aguilar M, Rivera-Lebron B, Kim NH, et al. Vascular Disease Patient Information Page: Post-pulmonary embolism syndrome, CTEPD, and CTEPH. Vasc Med. 2024 Jul 29:1358863X241258957. doi: 10.1177/1358863X241258957. |
2 | 38846991 | 0 | Del Toro Mijares R, Rojas Murguia A, Porres-Aguilar M, et al. Anticoagulation in the Management of Acute Pulmonary Embolism-A Review. Int J Angiol. 2024 Mar 12;33(2):95-100. doi: 10.1055/s-0044-1782537. eCollection 2024 Jun. |
3 | 38153027 | 0 | Porres-Aguilar M, Najera C, Mares AC, et al. Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis. Angiology. 2023 Dec 28:33197231225291. doi: 10.1177/00033197231225291. |
4 | 38089875 | 0 | Jerjes-Sanchez C, Porres-Aguilar M. Editorial: Pulmonary embolism-New diagnostic and therapeutic strategies. Front Med (Lausanne). 2023 Nov 28;10:1281073. doi: 10.3389/fmed.2023.1281073. eCollection 2023. |
5 | 37947131 | 0 | Prakash S, Mares AC, Porres-Aguilar M, et al. Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review. Vasc Med. 2023 Nov 10:1358863X231206778. doi: 10.1177/1358863X231206778. |
6 | 37576730 | 0 | Dah K, Porres-Aguilar M, la Rosa A, et al. Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism. J Vasc Bras. 2023 Jun 30;22:e20230056. doi: 10.1590/1677-5449.202300562. eCollection 2023. |
7 | 37416093 | 0 | Porres-Aguilar M. ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism. J Vasc Bras. 2023 Jun 19;22:e20230051. doi: 10.1590/1677-5449.202300512. eCollection 2023. |
8 | 36522193 | 0 | Porres-Aguilar M. Factor XI Inhibitors for the Prevention of Thrombosis: Towards Safer Anticoagulation Strategies. Arch Med Res. 2022 Dec 13:S0188-4409(22)00165-5. doi: 10.1016/j.arcmed.2022.11.018. |
9 | 36481128 | 0 | Porres-Aguilar M, Ansell J, Mukherjee D, et al. Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs. Arch Med Res. 2022 Dec 5:S0188-4409(22)00163-1. doi: 10.1016/j.arcmed.2022.11.016. |
10 | 36076354 | 0 | Porres-Aguilar M, Mukherjee D, Didia SC, et al. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies. Vascular. 2022 Sep 8:17085381221126235. doi: 10.1177/17085381221126235. |